News and Events
News and Events
You may sort news and events by title or recency. If you wish to view only news, please select the news link from the left. If you wish to see events at which Quintiles is scheduled to participate, please select the events link from the left.
- Sort by: Most Recent
- Title
-
HOECHST MARION ROUSSEL AND QUINTILES ANNOUNCE STRATEGIC PARTNERSHIP AGREEMENT
December 14, 1998 - Hoechst Marion Roussel, Inc., the global pharmaceutical company of Hoechst AG, and Quintiles Transnational Corp. (Nasdaq: QTRN), the leading provider of product development services to the pharmaceutical industry, today announced the signing of a letter of intent to negotiate a definitive agreement under which Quintiles will acquire substantial assets of Hoechst Marion Roussel's Kansas City-based Drug Innovation and Approval (DI&A) organization and open a Kansas City contract research facility. The agreement includes plans to employ approximately 540 current Hoechst Marion Roussel employees based in Kansas City, Mo. -
QUINTILES OPENS OFFICE IN BRAZIL, THE WORLD'S SIXTH-LARGEST PHARMACEUTICAL MARKET
October 15, 1998 - Quintiles Transnational Corp. (Nasdaq: QTRN) today announced the opening of an office in Sao Paulo, Brazil, further expanding the company's ability to serve pharmaceutical customers in Latin America and globally. -
QUINTILES ACQUIRES U.S. MEDICAL MARKETING & COMMUNICATIONS COMPANY
October 14, 1998 - Quintiles Transnational Corp. (Nasdaq: QTRN) announced today the acquisition of Q.E.D. International Inc., a New York-based provider of integrated product marketing and communication services for pharmaceutical companies in the U.S. market. -
QUINTILES ACQUIRES CLINICAL PACKAGING SERVICES COMPANY
October 12, 1998 - Quintiles Transnational Corp. (Nasdaq: QTRN) announced today the acquisition of Simirex Inc. and Simirex International Ltd., which provide clinical packaging services for the pharmaceutical industry. -
QUINTILES OPENS OFFICE IN ISRAEL
September 2, 1998 - Quintiles Transnational Corp. (Nasdaq: QTRN) today announced the opening of an office in Israel, expanding its ability to provide a full range of pharmaceutical development services in that country. -
QUINTILES, JOHNS HOPKINS TO COLLABORATE ON CLINICAL RESEARCH
July 27, 1998 - Quintiles Transnational Corp. (Nasdaq: QTRN) announced today the signing of an agreement with Johns Hopkins Medicine to collaborate on clinical research opportunities. The non-exclusive agreement also calls for Johns Hopkins to participate in Quintiles' Select Sites(TM) program. -
QUINTILES, EMORY UNIVERSITY TO COLLABORATE ON CLINICAL RESEARCH
June 30, 1998 - Quintiles Transnational Corp. (Nasdaq: QTRN) announced today the signing of an agreement with Emory University to collaborate on clinical research opportunities. The non-exclusive agreement also calls for Emory to participate in Quintiles' Select Sites(TM) program. -
QUINTILES ADDS TO GLOBAL BIOSTATISTICS & INTERNATIONAL ECG MONITORING THROUGH ACQUISITIONS IN SOUTH AFRICA AND U.K.
June 29, 1998 - Quintiles Transnational Corp. (Nasdaq: QTRN) announced today the acquisitions of ClinData International Pty Ltd., South Africa’s leading biostatistics and data management company, and U.K.-based Cardiac Alert, which provides a centralized electrocardiogram (ECG) monitoring service for international clinical trials. -
QUINTILES OPENS OFFICES IN BULGARIA AND HUNGARY, FURTHER EXPANDING ITS SERVICES IN EASTERN EUROPE
June 9, 1998 - Quintiles Transnational Corp. (Nasdaq: QTRN) today announced the opening of offices in Bulgaria and Hungary, further expanding its ability to provide pharmaceutical development services in Eastern Europe. -
QUINTILES LAUNCHES 'ACCELERATED SITE RESOURCES,' A NEW SERVICE OFFERING FOR SPONSORS & INVESTIGATORS
June 5, 1998 - Quintiles Transnational Corp. (Nasdaq: QTRN) today announced an important new service offering in its TotalAcceleration program to streamline and improve clinical trials. Called Accelerated Site Resources, the service will provide Clinical Research Coordinators (CRCs) who will perform a wide range of services at investigator sites, from the implementation of new electronic data collection systems to turn-key study management.